Advertisement

The Effects of Thyrotropin-Releasing Hormone (TRH) and other Drugs on the Actions of Alcohol

  • Richard B. Mailman
  • Gerald D. Frye
  • Robert A. Mueller
  • George R. Breese
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 126)

Abstract

During the past several years, our laboratory has sought compounds that would antagonize actions of ethanol. This strategy was undertaken not only to study putative amethystic agents (Erickson, 1979), but also to provide information about biological mechanisms by which ethanol alters central nervous system (CNS) function. Thus, if a putative antagonist were found that altered all actions of ethanol, it might be possible to link the effects of ethanol to a single neurobiological mechanism. Furthermore, if the pharmacological actions of the antagonist were well enough defined, predictions could be made concerning specific neural mechanisms intrinsic to specific actions of ethanol. The research described will use this general perspective, and focus on studies that were conducted to examine the effects of thyrotropin-releasing hormone (TRH) against ethanol.

Keywords

Thyrotropin Release Hormone Cerebral Cortical Neuron Thyrotropin Release Hormone Cerebellar cGMP Putative Antagonist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bassiri, R.M. and Utiger, R.D. The preparation and specificity of antibody to thyrotropin releasing hormone. Endocrinology 90: 722–727 (1972).PubMedCrossRefGoogle Scholar
  2. Bowers, C.Y., Friesen, H.G., Hwang, P., Guyda, H.J. and Folkes, K. Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide. Biochem. Biophys. Res. Commun. 45: 1033–1041 (1971).PubMedCrossRefGoogle Scholar
  3. Breese, G.R., Cott, J.M., Cooper, B.R., Prange, A.J., Jr. and Lipton, M.A. Antagonism of ethanol narcosis by thyrotropin releasing hormone. Life Sci. 14: 1053–1063 (1974).PubMedCrossRefGoogle Scholar
  4. Breese, G.R., Cott, J.M., Cooper, B.R., Prange, A.J., Jr., Lipton, M.A. and Plotnikoff, N.P. Effects of thyrotropin-releasing hormone on the actions of pentobarbital and other centrally acting drugs. J. Pharmacol. Exp. Ther. 193: 11–22 (1975).PubMedCentralPubMedGoogle Scholar
  5. Carlsson, A., Engel, J., Strombom, U., Svensson, T.H. and Waldeck, B. Suppression by dopamine agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis. Naunyn-Schmiedeberg’s Arch. Pharmacol. 283: 117–128 (1978).CrossRefGoogle Scholar
  6. Cornford, E.M., Braun, L.D., Crane, P.D. and Oldendorf, W.H. Blood- brain barrier restriction of peptides and the low uptake of enkephalins. Endocrinology 103: 1297–1303 (1978).PubMedCrossRefGoogle Scholar
  7. Cott, J.M., Breese, G.R., Cooper, B.R., Barlow, T.S. and Prange, A, J., Jr. Investigations into the mechanisms of reduction of ethanol sleep by thyrotropin releasing hormone (TRH). J. Pharmacol. Exp. Ther. 196: 594–604 (1976).PubMedCentralPubMedGoogle Scholar
  8. Emerson, C.H., Frohman, L.A., Szabo, M. and Thakkar, I. TRH immuno-reactivity in human urine: Evidence for disassociation from TRH. J. Clin. Endo. Metab. 45: 392–399 (1977).CrossRefGoogle Scholar
  9. Erickson, C.K. Requirements for an ideal alcohol antagonist [THIS VOLUME] (1979).Google Scholar
  10. Guillemin, R. Peptides in the brain: The new endocrinology of the neuron. Science 202: 390–401 (1978).PubMedCrossRefGoogle Scholar
  11. Horita, A., Carino, M.A. and Weick, B.G. Effects of thyrotropin-releasing hormone (TRH) microinjected into various areas of conscious and pentobarbital-pretreated rabbits. Proc. West. Pharmacol. Soc. 19: 212–213 (1978).Google Scholar
  12. Horst, W.D. and Spirt, N. A possible mechanism for the antidepressant activity of thyrotropin releasing hormone. Life Sci. 15: 1073–1082 (1974).PubMedCrossRefGoogle Scholar
  13. Keller, H.H., Bartholini, G. and Pletscher, A. Enhancement of cerebral noradrenaline turnover by thyrotropin releasing hormone. Nature 248: 528–529 (1974).PubMedCrossRefGoogle Scholar
  14. Kraemer, G.N., Mueller, R.A., Breese, G.R., Prange, A.J., Jr., Lewis, J.K., Morrison, H. and McKinney, W.T. Thyrotropin releasing hormone: Antagonism of pentobarbital narcosis in the monkey. Pharmacol. Biochem. Behav. 4: 709–712 (1976).CrossRefGoogle Scholar
  15. Lundberg, D., Breese, G.R., Mailman, R.B., Frye, G.D. and Mueller, R.A. Depression of some drug-induced in vivo changes in cerebellar guanosine-3’,5’-monophosphate (cGMP) by control of motor and respiratory changes. Mol. Pharmacol., in press (1979).Google Scholar
  16. Mailman, R.B., Frye, G.D., Mueller, R.A. and Breese, G.R. Thyrotropin-releasing hormone reversal of ethanol-induced decreases in cerebellar cGMP. Nature 272: 832–833 (1978).PubMedCrossRefGoogle Scholar
  17. Mailman, R.B., Frye, G.D., Mueller, R.A. and Breese, G.R. Change in brain guanosine-3’,5’-monophosphate (cGMP) content by thyrotropin releasing hormone. J. Pharmacol. Exp. Ther., in press (1979).Google Scholar
  18. Mailman, R.B., Mueller, R.A., Frye, G.D. and Breese, G.R. Thyrotropin-releasing hormone (TRH) elevates cerebellar cGMP levels. Neurosci. Abstr. 3: 444 (1977).Google Scholar
  19. Mueller, R.A., Lundberg, D., Frye, G.D., Mailman, R.B. and Breese, G.R. Cerebellar cGMP varies with motor function and respiratory gas exchange. Neurosci. Lett., in press (1978).Google Scholar
  20. Plotnikoff, N.P., Prange, A.J., Jr., Breese, G.R. and Anderson, M.S. Enhancement of DOPA activity by a hypothalamic hormone, thyrotropin-releasing hormone, TRH. Science 178: 417–418 (1972).Google Scholar
  21. Prange, A.J., Breese, G.R., Cott, J.M., Martin, B.R., Cooper, B.R., Wilson, I.e. and Plotnikoff, N.P. Thyrotropin-releasing hormone: Antagonism of pentobarbital in rodents. Life Sci. 14: 447–455 (1974).PubMedCrossRefGoogle Scholar
  22. Redding, T, W. and Schally, A.V. On the half-life of thyrotropin- releasing hormone in rats. Neuroendocrinology 9: 250–256 (1972).PubMedCrossRefGoogle Scholar
  23. Redos, J.D., Catravas, G, N. and Hunt, W.A. Ethanol-induced depletion of cerebellar guanosine-3’,5’-cyclic monophosphate. Science 193: 58–59 (1976).PubMedCrossRefGoogle Scholar
  24. Reigle, T.G., Avni, J., Platz, P.A., Schildkraut, J.J. and Plotnikoff, N.P. Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone. Psychopharmacologia 37: 1–6 (1974).PubMedCrossRefGoogle Scholar
  25. Schally, A.V. Aspects of hypothalamic regulation of the pituitary gland. Science 202:18–28 (1978).PubMedCrossRefGoogle Scholar
  26. Volicer, L. and Hurter, B.P. Effects of acute and chronic ethanol administration and withdrawal on adenosine-3’,5’-monophosphate and guanosine-3’,5’-monophosphate levels in the rat brain. J. Pharmacol, Exp. Ther. 200: 298–305 (1977).Google Scholar
  27. Yarbrough, G.C. TRH potentiates excitatory actions of acetyl choline on cerebral cortical neurons. Nature 263: 523–524 (1976).PubMedCrossRefGoogle Scholar
  28. Yarbrough, G.C. Studies on the neuropharmacology of thyrotropin releasing hormone (TRH) and a new TRH analog. Eur. J. Pharmacol. 48: 19–27 (1978).PubMedCrossRefGoogle Scholar
  29. Youngblood, W.W., Lipton, M.A. and Kizer, J.S. TRH-like immuno- reactivity in urine, serum and extrahypothalamic brain: Non-identity with synthetic [pyroGlu-Hist-Pro-NH2] (TRH). Brain Res. 151: 99–116 (1978).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • Richard B. Mailman
    • 1
  • Gerald D. Frye
    • 1
  • Robert A. Mueller
    • 1
  • George R. Breese
    • 1
  1. 1.Departments of Psychiatry, Pharmacology and Anesthesiology, and the Biological Sciences Research CenterUniversity of North Carolina, School of MedicineChapel HillUSA

Personalised recommendations